CD44 promotes tumor progression through the activation of low molecular weight hyaluronan, which in turn activates signaling pathways promoting cell migration and invasion, or by acting as a co-receptor to oncogenes (c-Met and ErbB receptors). Here, CD44 is linked to neoplasm.